Jia Rong, Guo Ji Hua, Fan Ming Wen, Bian Zhuan, Chen Zhi, Fan Bing, Yu Fei, Xu Qing An
Key Laboratory for Oral Biomedical Engineering of Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan 430079, PR China.
Vaccine. 2006 Jun 12;24(24):5192-200. doi: 10.1016/j.vaccine.2006.03.090. Epub 2006 Apr 19.
Enhancement of mucosal and systemic immune responses is still a challenge for the application of DNA vaccine. Here, we show anti-caries DNA vaccines, pGJA-P and pGJA-P/VAX, encoding Streptococcus mutans antigens fused to cytotoxic T lymphocyte antigen-4 (CTLA4), which binds to B7 molecule expressed on the surfaces of antigen-presenting cells. Rabbits and monkeys were immunized via intranasal or intramuscular routes. The fusion vaccine induced accelerated and increased specific antibody responses in serum and saliva compared with non-fusion DNA vaccine in rabbits. Significant specific serum IgG and salivary IgA levels could be detected in fusion vaccine-immunized monkeys. Therefore, this study demonstrates that fusing antigens to CTLA4 results in enhancing immune efficacy and strongly suggests that it may represent a promising approach to prevent dental caries or other mucosal infectious diseases. These findings also suggest that CTLA4 fusion anti-caries DNA vaccine may be effective immunogen in primates.
增强黏膜和全身免疫反应仍然是DNA疫苗应用面临的一项挑战。在此,我们展示了抗龋DNA疫苗pGJA-P和pGJA-P/VAX,它们编码与细胞毒性T淋巴细胞抗原4(CTLA4)融合的变形链球菌抗原,CTLA4可与抗原呈递细胞表面表达的B7分子结合。通过鼻内或肌肉内途径对兔子和猴子进行免疫接种。与非融合DNA疫苗相比,融合疫苗在兔子体内诱导血清和唾液中特异性抗体反应加速且增强。在融合疫苗免疫的猴子中可检测到显著的特异性血清IgG和唾液IgA水平。因此,本研究证明将抗原与CTLA4融合可提高免疫效力,并强烈表明这可能是预防龋齿或其他黏膜感染性疾病的一种有前景的方法。这些发现还表明CTLA4融合抗龋DNA疫苗可能是灵长类动物有效的免疫原。